Literature DB >> 22653886

Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10.

Ghida Aljuburi1, Anthony A Laverty, Stuart A Green, Karen J Phekoo, Ricky Banarsee, N V Ogo Okoye, Derek Bell, Azeem Majeed.   

Abstract

BACKGROUND: Sickle cell disease (SCD) is a rising cause of mortality and morbidity in England and consequently an important policy issue for the National Health Service. There has been no previous study that has examined SCD admission rates in England.
METHODS: Data from Hospital Episode Statistics were analysed for all hospital episodes (2001/10) in England with a primary diagnosis of sickle cell anaemia with crisis (D57.0) or without crisis (D57.1). Secondary and tertiary diagnoses were examined among those patients admitted with either of these codes as their primary diagnosis.
RESULTS: The overall SCD admission rate per 100 000 has risen from 21.2 in 2001/02 to 33.5 in 2009/10, a rise of over 50%. London accounts for 74.9% of all SCD admissions in England. 57.9% of patients admitted are discharged within 24 h. The largest rise in admission rates was seen among males aged 40-49 years where admission rates per 100 000 increased from 7.6 to 26.8 over the study period.
CONCLUSIONS: Our data show that SCD admissions are rising in England, particularly in London. Over half of patients admitted with SCD were discharged within 24 h, suggesting that some of these admissions could be prevented through better ambulatory care of patients.

Entities:  

Mesh:

Year:  2012        PMID: 22653886     DOI: 10.1093/pubmed/fds035

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  13 in total

1.  Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease.

Authors:  Robert M Cronin; Manshu Yang; Jane S Hankins; Jeannie Byrd; Brandi M Pernell; Adetola Kassim; Patricia Adams-Graves; Alexis A Thompson; Karen Kalinyak; Michael DeBaun; Marsha Treadwell
Journal:  Hematology       Date:  2020-12       Impact factor: 2.269

2.  A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.

Authors:  E Pizzo; A A Laverty; K J Phekoo; G AlJuburi; S A Green; D Bell; A Majeed
Journal:  J Public Health (Oxf)       Date:  2014-05-05       Impact factor: 2.341

Review 3.  Psychological therapies for sickle cell disease and pain.

Authors:  Kofi A Anie; John Green
Journal:  Cochrane Database Syst Rev       Date:  2015-05-08

4.  Increased Patient Activation Is Associated with Fewer Emergency Room Visits and Hospitalizations for Pain in Adults with Sickle Cell Disease.

Authors:  Robert M Cronin; Tim Lucas Dorner; Amol Utrankar; Whitney Allen; Mark Rodeghier; Adetola A Kassim; Gretchen Purcell Jackson; Michael R DeBaun
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

5.  Associations between environmental factors and hospital admissions for sickle cell disease.

Authors:  Frédéric B Piel; Sanjay Tewari; Valentine Brousse; Antonis Analitis; Anna Font; Stephan Menzel; Subarna Chakravorty; Swee Lay Thein; Baba Inusa; Paul Telfer; Mariane de Montalembert; Gary W Fuller; Klea Katsouyanni; David C Rees
Journal:  Haematologica       Date:  2016-12-01       Impact factor: 9.941

6.  Views of patients about sickle cell disease management in primary care: a questionnaire-based pilot study.

Authors:  G Aljuburi; O Okoye; A Majeed; Y Knight; Sa Green; R Banarsee; A Nkohkwo; P Ojeer; C Ndive; L Oni; Kj Phekoo
Journal:  JRSM Short Rep       Date:  2012-11-30

7.  Patients' views on improving sickle cell disease management in primary care: focus group discussion.

Authors:  Ghida Aljuburi; Karen J Phekoo; Nv Ogo Okoye; Kofie Anie; Stuart A Green; Asaah Nkohkwo; Patrick Ojeer; Comfort Ndive; Ricky Banarsee; Lola Oni; Azeem Majeed
Journal:  JRSM Short Rep       Date:  2012-12-27

8.  Trends in hospital admissions for sickle cell disease in England.

Authors:  Radoslav Latinovic; Allison Streetly
Journal:  J Public Health (Oxf)       Date:  2013-02-05       Impact factor: 2.341

9.  SWIM (sickle with ibuprofen and morphine) randomised controlled trial fails to recruit: lessons learnt.

Authors:  Gavin Cho; Kofi A Anie; Jacky Buckton; Patricia Kiilu; Mark Layton; Lydia Alexander; Claire Hemmaway; Dorothy Sutton; Claire Amos; Caroline J Doré; Brennan Kahan; Sarah Meredith
Journal:  BMJ Open       Date:  2016-06-09       Impact factor: 2.692

10.  Improving routine outpatient monitoring for patients with sickle-cell disease on hydroxyurea.

Authors:  Joel Ward; Natasha Lewis; Dimitris A Tsitsikas
Journal:  BMJ Open Qual       Date:  2018-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.